Association of serum fetuin-A levels with mortality in dialysis patients
- 1 July 2007
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 72 (2) , 202-207
- https://doi.org/10.1038/sj.ki.5002178
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: Association With Mortality in Dialysis PatientsAmerican Journal of Kidney Diseases, 2005
- Arteriosclerosis, calcium phosphate deposition and cardiovascular disease in uremia: current concepts at the benchCurrent Opinion in Nephrology and Hypertension, 2005
- Vascular calcificationCurrent Opinion in Nephrology and Hypertension, 2005
- Vascular calcification in chronic kidney diseaseAmerican Journal of Kidney Diseases, 2004
- Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortalityNephrology Dialysis Transplantation, 2003
- The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcificationJournal of Clinical Investigation, 2003
- Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal DiseaseHypertension, 2001
- Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing DialysisNew England Journal of Medicine, 2000
- Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national studyAmerican Journal of Kidney Diseases, 1998
- Accelerated Atherosclerosis in Prolonged Maintenance HemodialysisNew England Journal of Medicine, 1974